Lobbyist information

Amount

George Atanasov

$51,250.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2018 Areas of focus will be any issues that impact Johnson & Johnson companies, including but not limited to medical device, consumer, pharmaceuticals, health care reform, wellness initiatives, tax and environment. Contacts related to these issues are expected to be made with the Executive Offices of the Governor and Lieutenant Governor, the Office of the Secretary of Health and Human Services, the Department of Public Health, the Health Policy Commission, the Department of Environmental Protection as well as the Legislature. Bills or issues of likely focus: SB 652, An Act to promote transparency and prevent price gouging of pharmaceutical drug prices SB 627, An Act to promote transparency in prescription drug prices HB 490, An Act relative to ensuring transparency of health plan formularies HB 1228, An Act to promote transparency and cost control of pharmaceutical drug prices HB 3223, An Act to promote transparency in prescription drug prices SB 516, An Act relative to out-of-pocket expenses for prescription drug coverage SB 550, An Act relative to ensuring transparency of health plan formularies SB 637, An Act to define modest meals and refreshments in prescriber education settings SB 1163, An Act relative to transparency and access in healthcare SB 1209, An Act relative to the in-office sales of medical devices and products SB 1215, An Act to reduce healthcare costs by promoting non-biased prescriber education SB 1233, An Act to restore integrity in the marketing of pharmaceutical products and medical devices HB 2371, An Act relative to non-competition agreements SB 1020, An Act to protect trade secrets and eliminate non-compete agreements HB 143, An Act relative to the digital right to repair SB 96, An Act relative to the digital right to repair Advocacy for the Department of Public Health to commence promulgation of regulations relative to a pharmacist's authority under the law to administer injections of certain mental health and substance abuse medications. FY 18 budget Continued Implementation of Chapter 224 Economic Development Policies

Total salaries paid:      $51,250.00

Lobbyist Entity information

Amount

ML Strategies, LLC	$36,159.34
Employed Terminated 01/01/2018

Total salaries paid:      $36,159.34

Expenditures

Amount